Secondary breast cancer after treatment for Hodgkin’s diseas
Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...Now open: Certificate Course in Management of Covid-19 by Govt. Of Gujarat and PlexusMDKnow more...
Improved survival of patients treated for Hodgkin’s disease has been increased at the cost of late complications, the most frequent of which are secondary neoplasias such as breast cancers, which account for 6–9% of these neoplasias after treatment for MDH.The most favorable factors are mainly young age and radiotherapy. A 34 years old female, married and mother of one child, menarcheal age at 13 years old, not menopausal and she took oral contraceptives for about four years; there is no known family history of breast or ovarian cancer. She was treated at the age of 17 for Hodgkin’s disease initially classified as stage III supra and under diaphragmatic with first-line chemotherapy: cyclophosphamide, vincristine, prednisone and procarbazine hydrochloride (8 cures) followed by diaphragmatic irradiation mantle; 36 Gy in 18 sessions and irradiation of the lomboartic and the spleen.The patient was followed regularly and then lost sight of, and come back 17 years later for a right breast nodal in external super-quadrant, 3 cm in size, classified IV according to American College of Radiology; associated with an axillary ganglion infracentimetric. The extension report was normal (computed tomography thoracic-abdominal-pelvic and bone scan)....

http://www.edoriumjournals.com/journal-of-case-reports-and-images-in-oncology/archive/2017-archive/100038Z10LB2017-loubna/100038Z10LB2017-loubna-full-text.php
Preview
Like
Comment
Share